| 000 | 01819 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517101939.0 | ||
| 264 | 0 | _c20170814 | |
| 008 | 201708s 0 0 eng d | ||
| 022 | _a1178-2005 | ||
| 024 | 7 |
_a10.2147/COPD.S103281 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKoo, Hyeon-Kyoung | |
| 245 | 0 | 0 |
_aRelationship between plasma matrix metalloproteinase levels, pulmonary function, bronchodilator response, and emphysema severity. _h[electronic resource] |
| 260 |
_bInternational journal of chronic obstructive pulmonary disease _c2016 |
||
| 300 |
_a1129-37 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBronchodilator Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aForced Expiratory Volume |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLinear Models |
| 650 | 0 | 4 |
_aLung _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 1 _xblood |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 12 _xblood |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 8 _xblood |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xblood |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xblood |
| 650 | 0 | 4 |
_aPulmonary Emphysema _xblood |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUp-Regulation |
| 650 | 0 | 4 | _aVital Capacity |
| 700 | 1 | _aHong, Yoonki | |
| 700 | 1 | _aLim, Myoung Nam | |
| 700 | 1 | _aYim, Jae-Joon | |
| 700 | 1 | _aKim, Woo Jin | |
| 773 | 0 |
_tInternational journal of chronic obstructive pulmonary disease _gvol. 11 _gp. 1129-37 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2147/COPD.S103281 _zAvailable from publisher's website |
| 999 |
_c26133772 _d26133772 |
||